Events

Join the Symeres team at the 6th RSC-BMCS/DMDG New Perspectives in DMPK in Liverpool! Sascha Hartmann, Director of Business Development, and Laszlo Szilagyi, Director of Business Development at Admescope (a Symeres company), will be delighted to discuss how we can support you. We have extensive experience in small molecules drug R&D, but also molecular glues, PROTACs, macrocycles, and many other modalities. Additionally, let’s explore our ADME-Tox profiling platform and in vivo DMPK services to support your pharmaceutical discovery and development programs. Stop by our booth number 3; we are eager to assist you!

Symeres will be present at Chemspec Europe 2024, the 37th International Exhibition for Fine and Speciality Chemicals, June 19-20, 2024, in Hall 3 at Messe Düsseldorf in Germany. The team will consist of André de Vries, Director of Innovation and Business Development, and Kirill Kulish, Business Development Scientist. André will deliver a presentation on one of his favorite topics, “Green Chemistry in Drug Development and Manufacturing.” It’s important to produce drugs with as little harm to our planet as possible! If you’re curious about this topic or want to learn more about Symeres’ capabilities, please send André de Vries or Kirill Kulish a personal message. Make sure to reach out to our team and meet them at Chemspec!

Symeres is happy to announce that our Head of Business Development Russell Thomas and our VP Business Development Bart DeCorte will be representing Symeres at The 38th National Medicinal Chemistry Symposium in Seattle, WA, from June 23-26. Our team will be joined by Maria Pia Catalani, Director Lead Discovery at our long-term partner Axxam. You can visit us at booth number 10. Our seasoned team brings a wealth of knowledge and innovation, so join them to explore cutting-edge research, discuss the latest industry trends, and discover how Symeres is pushing the boundaries of drug discovery and development. Don’t miss this opportunity to connect with Russell, Bart, and Maria Pia, to network with fellow professionals, and gain insights into the future of medicinal chemistry. Please contact Bart via Bart.DeCorte@Symeres.com if you want to set up a meeting upfront. See you in Seattle!

Symeres is happy to announce its participation at the 58th International Conference on Medicinal Chemistry (RICT 2024), happening in Bordeaux, France, from July 3-5! Our team, consisting of Norimasa Morita, Director of Business Development; Ana Rioz, Business Development Scientist; and Luc Van Hijfte, Senior VP Drug Discovery at Symeres and EFMC President, will be attending. Join us at this inspiring event focused on bridging Chemical Biology and Drug Discovery. We are eager to learn more about RNA Binding Molecules, new modalities for Drug Discovery, recent trends in CNS disease drug development, and much more. Are you curious about Symeres’ expertise on these topics and want to engage in a discussion with us? Make sure to visit our booth, number 24! We look forward to seeing you there and exploring how we can collaborate!

We are excited to announce that Russ Thomas, Sascha Hartmann, and Laszlo Szilagyi will represent Symeres at the XXVIII EFMC International Symposium on Medicinal Chemistry in Rome, Italy, from September 1-5, 2024. This is a key event in the medicinal chemistry and drug discovery calendar, attracting around 1,000 participants from both industry and academia. The EFMC-ISMC 2024 will feature plenary sessions with lectures by renowned experts like Prof. David MacMillan (Princeton University), Prof. Véronique Gouverneur (University of Oxford), and Dr. Emma Parmee (Janssen Pharmaceutica). The programme includes the presentation of several prestigious awards and covers themes such as Chemical Biology, Drug Discovery Projects, and Technologies, along with special sessions on topics like Early Career Women in Medicinal Chemistry. We look forward to engaging with the community and exploring the latest advancements in our field. Join us at this event by visiting our booth #54!